<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01750593</url>
  </required_header>
  <id_info>
    <org_study_id>yelizeminersoy</org_study_id>
    <nct_id>NCT01750593</nct_id>
  </id_info>
  <brief_title>Radiofrequency Ablation in Thyroid Nodules</brief_title>
  <official_title>Efficacy of Radiofrequency Ablation in Thyroid Nodules</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thyroid nodules are common problems and although &gt; 95% are stated to be benign, they may
      cause some problems like hyperthyroidism, compression symptoms, and cosmesis associated with
      their function, size and localization. Especially for these nodules, patients undergo surgery
      and face up with the problems associated with surgical complications although they are not
      cancer. In some studies, radiofrequency ablation previously used for intrabdominal tumors
      like hepatic metastasis...,was stated to be efficient in the treatment of benign thyroid
      nodules and in some recurrent thyroid cancer cases. Therefore, the investigators decided to
      use this method in our patients having nodules like previously mentioned and see the efficacy
      and safety of the technique.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Shrinkage of the thyroid nodule after radiofrequency ablation</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disappearance of the nodules in follow up</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Thyroid Nodules</condition>
  <arm_group>
    <arm_group_label>radiofrequency ablation of thyroid nodule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Under ultrasonography the thyroid nodules will be ablated by radiofrequency ablation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency ablation of the thyroid nodule</intervention_name>
    <description>Under USG control, the nodule will be ablated by radiofrequency with a needle that has an active tip of 1 cm.</description>
    <arm_group_label>radiofrequency ablation of thyroid nodule</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. the presence of subjective symptoms (foreign body sensation, neck discomfort or pain,
             compressive symptom) or cosmetic problems;

          2. a poor surgical candidate or refusal to undergo surgery;

          3. fine-needle aspiration cytology and US findings that were compatible with a benign
             nodule;

          4. anxiety about a malignancy.

        Exclusion Criteria:

          1. a nodule less than 5 mm in size;

          2. follicular neoplasm or malignancy on fine needle aspiration cytology (FNAC);

          3. a nodule with the sonographic criteria for a malignancy (taller than wide, marked
             hypoechoic, microcalcifications, ill-defined margins), although FNAC was a benign
             result;

          4. previous radiation or operation history to the head and neck; (5) previous sclerosing
             therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Erhan Aysan, Prof. Dr.</last_name>
    <email>erhanaysan@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yeliz Ersoy, Assoc.Prof</last_name>
    <email>yelizemineersoy@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bezmialem Vakif University medical Faculty</name>
      <address>
        <city>Istanbul</city>
        <zip>34308</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erhan Aysan, Prof. Dr.</last_name>
      <email>erhanaysan@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bezmialem Vakif University</name>
      <address>
        <city>Istanbul</city>
        <zip>34308</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erhan Aysan, Prof</last_name>
      <phone>902124531700</phone>
      <phone_ext>4116</phone_ext>
      <email>erhanaysan@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Yeliz Ersoy, Assoc. Prof</last_name>
      <phone>902124531700</phone>
      <phone_ext>4506</phone_ext>
      <email>yelizemineersoy@yahoo.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Bezmialem Vakif University</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ERHAN AYSAN, PROF.</last_name>
      <phone>902124531700</phone>
      <email>yelizemineersoy@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2012</study_first_submitted>
  <study_first_submitted_qc>December 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2012</study_first_posted>
  <last_update_submitted>November 27, 2013</last_update_submitted>
  <last_update_submitted_qc>November 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bezmialem Vakif University</investigator_affiliation>
    <investigator_full_name>Yeliz Emine Ersoy</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>radiofrequency</keyword>
  <keyword>thyroid</keyword>
  <keyword>nodule</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Nodule</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

